Correlation Between SpringWorks Therapeutics and Ocular Therapeutix
Can any of the company-specific risk be diversified away by investing in both SpringWorks Therapeutics and Ocular Therapeutix at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SpringWorks Therapeutics and Ocular Therapeutix into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between SpringWorks Therapeutics and Ocular Therapeutix, you can compare the effects of market volatilities on SpringWorks Therapeutics and Ocular Therapeutix and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SpringWorks Therapeutics with a short position of Ocular Therapeutix. Check out your portfolio center. Please also check ongoing floating volatility patterns of SpringWorks Therapeutics and Ocular Therapeutix.
Diversification Opportunities for SpringWorks Therapeutics and Ocular Therapeutix
0.4 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between SpringWorks and Ocular is 0.4. Overlapping area represents the amount of risk that can be diversified away by holding SpringWorks Therapeutics and Ocular Therapeutix in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ocular Therapeutix and SpringWorks Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SpringWorks Therapeutics are associated (or correlated) with Ocular Therapeutix. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ocular Therapeutix has no effect on the direction of SpringWorks Therapeutics i.e., SpringWorks Therapeutics and Ocular Therapeutix go up and down completely randomly.
Pair Corralation between SpringWorks Therapeutics and Ocular Therapeutix
Given the investment horizon of 90 days SpringWorks Therapeutics is expected to generate 7.25 times less return on investment than Ocular Therapeutix. But when comparing it to its historical volatility, SpringWorks Therapeutics is 7.81 times less risky than Ocular Therapeutix. It trades about 0.19 of its potential returns per unit of risk. Ocular Therapeutix is currently generating about 0.18 of returns per unit of risk over similar time horizon. If you would invest 790.00 in Ocular Therapeutix on April 24, 2025 and sell it today you would earn a total of 365.00 from holding Ocular Therapeutix or generate 46.2% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 77.05% |
Values | Daily Returns |
SpringWorks Therapeutics vs. Ocular Therapeutix
Performance |
Timeline |
SpringWorks Therapeutics |
Risk-Adjusted Performance
Good
Weak | Strong |
Ocular Therapeutix |
SpringWorks Therapeutics and Ocular Therapeutix Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with SpringWorks Therapeutics and Ocular Therapeutix
The main advantage of trading using opposite SpringWorks Therapeutics and Ocular Therapeutix positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SpringWorks Therapeutics position performs unexpectedly, Ocular Therapeutix can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ocular Therapeutix will offset losses from the drop in Ocular Therapeutix's long position.SpringWorks Therapeutics vs. Revolution Medicines | SpringWorks Therapeutics vs. Blueprint Medicines Corp | SpringWorks Therapeutics vs. Stoke Therapeutics | SpringWorks Therapeutics vs. Cytokinetics |
Ocular Therapeutix vs. Day One Biopharmaceuticals | Ocular Therapeutix vs. X4 Pharmaceuticals | Ocular Therapeutix vs. Mereo BioPharma Group | Ocular Therapeutix vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |